What are the preliminary results of the BMS-986460 trial for treating prostate cancer in adult males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

Can BMS-986365 (targeting androgen receptor degradation) reactivate Zytiga (abiraterone) in patients who have developed resistance?
What is the comparison between BMS-986365 (Beclabuvir) and HLD-0915 in terms of efficacy and safety?
What is the role of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in treating heavily pre-treated patients with metastatic castration-resistant prostate cancer?
What are the implications and considerations for using BMS-986365 (CC-94676) in treatment?
What were the phase II results of BMS-986365 (prostate cancer treatment) in patients with metastatic castration-resistant prostate cancer?
Is there a cure for herpes simplex virus (HSV) infection?
What is the best approach for anticoagulation and ruling out GI malignancy in a patient with stage IV lung cancer and a suspected GI malignancy in the RLQ, considering the use of enoxaparin (LMWH)?
What is the treatment approach for a patient with suspected transfluthrin toxicity, considering factors such as age, medical history, and severity of exposure?
What is intrauterine growth restriction (IUGR)?
Does a patient with preseptal cellulitis following a bee sting require antibiotic coverage?
What is the likelihood of lymphoma in a 22-year-old female patient with no cancer history, presenting with a 2.3 x 1.6 x 2.7cm hypervascular groin node (lymph node) with preserved fatty hilum and mildly heterogenous cortex, accompanied by symptoms of intermittent itching, back pain, fatigue, weakness, and a newly developed node near the ear?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.